Evidence map›Paper›PMID 30782959›Full record

ArticleJournal of lipid research2019

Rosiglitazone remodels the lipid droplet and britens human visceral and subcutaneous adipocytes ex vivo.

Mi-Jeong Lee, Sukanta Jash, Jessica E C Jones, Vishwajeet Puri, Susan K Fried

Open access · hybridAbstract read
In one paragraph

Article in Journal of lipid research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 2 pooled it
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 2 syntheses or guidelines pooled it, 55 citations in OpenAlex.

  1. Pooled it
  2. New Mediators in the Crosstalk between Different Adipose Tissues.International journal of molecular sciences · 2024
    Pooled it
  3. iScience · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Deletion of Spinophilin Promotes White Adipocyte Browning.Pharmaceuticals (Basel, Switzerland) · 2023
    Article
  12. Article
  13. Essential Roles of PPARs in Lipid Metabolism during Mycobacterial Infection.International journal of molecular sciences · 2021
    Review
  14. Article
  15. Article
  16. The biology of lipid droplet-bound mitochondria.Seminars in cell & developmental biology · 2020
    Review
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Mi-Jeong LeeDiabetes, Obesity, and Metabolism Institute, Icahn School of Medicine at Mount Sinai, New York, NY; Obesity Center, Boston University School of Medicine, Boston, MA. Electronic address: mi-jeong.lee1@mssm.edu.
Sukanta JashObesity Center, Boston University School of Medicine, Boston, MA; Department of Biomedical Sciences and Diabetes Institute, Heritage College of Osteopathic Medicine, Ohio University, Athens, OH.
Jessica E C JonesDepartment of Medicine, and Department of Biochemistry, Boston University School of Medicine, Boston, MA.
Vishwajeet PuriObesity Center, Boston University School of Medicine, Boston, MA; Department of Biomedical Sciences and Diabetes Institute, Heritage College of Osteopathic Medicine, Ohio University, Athens, OH.
Susan K FriedDiabetes, Obesity, and Metabolism Institute, Icahn School of Medicine at Mount Sinai, New York, NY; Obesity Center, Boston University School of Medicine, Boston, MA.
Boston University · US

Funding

SPECIAL ASSAY COREP30DK036836 · NIDDK · JOSLIN DIABETES CENTER · PI JEAN E. SCHAFFER · 1986 to 2026
$50.5M
Transgenic CoreP30DK046200 · NIDDK · TUFTS MEDICAL CENTER · PI HU, FRANK B · 1992 to 2021
$25.0M
Statistics and Bioinformatics Core - WangU24DK097153 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI BURANT, CHARLES F · 2012 to 2017
$10.1M
Boston University Clinical and Translational Science Institute - U ProgramU54TR001012 · NCATS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI CENTER, DAVID M. · 2014 to 2014
$3.9M
Glucocorticoids & Adipocyte Function in Human ObesityR01DK080448 · NIDDK · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI FRIED, SUSAN K · 2009 to 2018
$3.4M
Cide Proteins and Regulation of Energy ExpenditureR01DK101711 · NIDDK · OHIO UNIVERSITY ATHENS · PI PURI, VISHWAJEET · 2014 to 2016
$1.1M
NCATS NIH HHS U54 TR001012NIDDK NIH HHS P30 DK036836NIDDK NIH HHS P30 DK046200NIDDK NIH HHS R01 DK080448NIDDK NIH HHS R01 DK101711NIDDK NIH HHS U24 DK097153
6 · The paper itself

Abstract

Treatment with PPARγ agonists in vivo improves human adipocyte metabolism, but the cellular mechanisms and possible depot differences in responsiveness to their effects are poorly understood. To examine the ex vivo metabolic effects of rosiglitazone (Rosi), we cultured explants of human visceral (omental) and abdominal subcutaneous adipose tissues for 7 days. Rosi increased mRNA levels of transcriptional regulators of brite/beige adipocytes (PGC1α, PRDM16), triglyceride synthesis (GPAT3, DGAT1), and lipolysis (ATGL) similarly in adipose tissues from both depots. In parallel, Rosi increased key modulators of FA oxidation (UCP1, FABP3, PLIN5 protein), rates of FA oxidation, and protein levels of electron transport complexes, suggesting an enhanced respiratory capacity as confirmed in newly differentiated adipocytes. Rosi led to the formation of small lipid droplets (SLDs) around the adipocyte central lipid droplet; each SLD was decorated with redistributed mitochondria that colocalized with PLIN5. SLD maintenance required lipolysis and FA reesterification. Rosi thus coordinated a structural and metabolic remodeling in adipocytes from both visceral and subcutaneous depots that enhanced oxidative capacity. Selective targeting of these cellular mechanisms to improve adipocyte FA handling may provide a new approach to treat metabolic complications of obesity and diabetes.

Indexed as

AdipocytesAdipose TissueAdultAgedFemaleHumansHypoglycemic AgentsLipid DropletsMaleMiddle AgedOxidation-ReductionPhenotypeRosiglitazoneHypoglycemic AgentsRosiglitazoneadipose depotsfatty acid oxidationperilipinsprotein carbonylationthiazolidinedione

Identifiers

PMID30782959
PMCPMC6446708
OpenAlexW2917794751

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.